Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Fennec Pharmaceuticals Preliminary Report: Q4 Net Revenues Expected To Be $9.2M-$9.7M, Up 41%-49% Q/Q, FY23 Net Revenues Projected To Be $20.7M-$21.2M

Author: Benzinga Newsdesk | February 29, 2024 08:12am

Posted In: FENC